View in EDS HTML Full Text PDF Full Text

Update to a randomized controlled trial of lutetium-177-PSMA in Oligo-metastatic hormone-sensitive prostate cancer: the BULLSEYE trial.

Saved in:
Bibliographic Details
Title: Update to a randomized controlled trial of lutetium-177-PSMA in Oligo-metastatic hormone-sensitive prostate cancer: the BULLSEYE trial.
Authors: Privé, Bastiaan M.1 (AUTHOR), Janssen, Marcel J. R.1 (AUTHOR), van Oort, Inge M.2 (AUTHOR), Muselaers, Constantijn H. J.2 (AUTHOR), Jonker, Marianne A.3 (AUTHOR), van Gemert, Willemijn A.1 (AUTHOR), de Groot, Michel1 (AUTHOR), Westdorp, Harm4 (AUTHOR), Mehra, Niven4 (AUTHOR), Verzijlbergen, J. Fred1 (AUTHOR), Scheenen, Tom W. J.1 (AUTHOR), Zámecnik, Patrik1 (AUTHOR), Barentsz, Jelle O.1 (AUTHOR), Gotthardt, Martin1 (AUTHOR), Noordzij, Walter5 (AUTHOR), Vogel, Wouter V.6,7 (AUTHOR), Bergman, Andries M.8 (AUTHOR), van der Poel, Henk G.9 (AUTHOR), Vis, André N.10 (AUTHOR), Oprea-Lager, Daniela E.11 (AUTHOR)
Source: Trials. 11/4/2021, Vol. 22 Issue 1, p1-4. 4p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17456215
DOI:10.1186/s13063-021-05733-4